1 |
Liu WL, Liang HW, Lee MF, et al. The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit[J]. PLoS One, 2014, 9(9):e107975.
|
2 |
Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology[J]. Clin Microbiol Infect, 2006, 12(9):826-836.
|
3 |
Guerrero-Lozano I, Fernandez-Cuenca F, Galan-Sanchez F, et al. Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain[J]. Microb Drug Resist, 2015, 21(2):215-217.
|
4 |
Lemos EV, de la Hoz FP, Einarson TR, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis[J]. Clin Microbiol Infect, 2014, 20(5):416-423.
|
5 |
李耘,吕媛,郑波,等.中国细菌耐药监测研究2015-2016革兰氏阴性菌监测报告[J].中国临床药理学杂志,2017,33(23):2521-2542.
|
6 |
Mencacci A, Monari C, Leli C, et al. Typing of nosocomial outbreaks of Acinetobacter baumannii by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry[J]. J Clin Microbiol, 2013, 51(2):603-606.
|
7 |
Clinical and Laboratory Standards Institute. M100S. Performance standards for antimicrobial susceptibility testing: twenty-sixth edition[S]. Wayne PA: CLSI,2016.
|
8 |
Bartual SG, Seifert H, Hippler C, et al. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii[J]. J Clin Microbiol, 2005, 43(9):4382-4390.
|
9 |
Xu XM, Fan YF, Feng WY, et al. Antibiotic resistan-ce determinants of a group of multidrug-resistant Acinetobacter baumannii in China[J]. J Antibiot (Tokyo), 2014, 67(6):439-444.
|
10 |
Sender R, Fuchs S, Milo R. Revised estimates for the number of human and bacteria cells in the body[J]. PLoS Biol, 2016, 14(8):e1002533.
|
11 |
Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis[J]. Lancet Infect Dis, 2018, 18(3):318-327.
|
12 |
Chen Y, Gao J, Zhang H, et al. Spread of the blaOXA-23- Containing Tn2008 in Carbapenem-resistant Acinetobacter baumannii isolates grouped in CC92 from China[J]. Front Microbiol, 2017 (8):163.
|
13 |
杨青,周志慧,符一骐,等.浙江省碳青霉烯类抗生素耐药鲍曼不动杆菌多位点序列分型研究[J].中华检验医学杂志,2013,36(4):303-307.
|
14 |
Saffari F, Monsen T, Karmostaji A, et al. Significant spread of extensively drug-resistant Acinetobacter baumannii genotypes of clonal complex 92 among intensive care unit patients in a university hospital in southern Iran[J]. J Med Microbiol, 2017, 66(11):1656-1662.
|
15 |
Longtin J, Seah C, Siebert K, et al. Distribution of antiseptic resistance genes qacA, qacB, and smr in methicillin-resistant Staphylococcus aureus isolated in Toronto, Canada, from 2005 to 2009[J]. Antimicrob Agents Chemother, 2011, 55(6):2999-3001.
|
16 |
Furi L, Ciusa ML, Knight D, et al. Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2013, 57(8):3488-3497.
|
17 |
Fernandez-Cuenca F, Tomas M, Caballero-Moyano FJ, et al. Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect on the expression of genes encoding porins and efflux pumps[J]. J Antimicrob Chemother, 2015, 70(12):3222-3229.
|
18 |
Rajamohan G, Srinivasan VB, Gebreyes WA. Novel role of Acinetobacter baumannii RND efflux transporters in mediating decreased susceptibility to biocides[J]. J Antimicrob Chemother, 2010, 65(2):228-232.
|
19 |
Munoz-Price LS, Zembower T, Penugonda S, et al. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak[J]. Infect Control Hosp Epidemiol, 2010, 31(10):1057-1062.
|
20 |
Munoz-Price LS, Namias N, Cleary T, et al. Acinetobacter baumannii: association between environmental contamination of patient rooms and occupant status[J]. Infect Control Hosp Epidemiol, 2013, 34(5):517-520.
|
21 |
AFNOR NF-S-90-351. Etablissements de sante. Zones a environnement maitrise. Exigences relatives a` la maitrise de la contamination aeroportee[S]. La Plaine Saint-Denis, France: Association Francaise de Normalisation, 2013.
|
22 |
Attaway HH 3rd, Fairey S, Steed LL, et al. Intrinsic bacterial burden associated with intensive care unit hospital beds: effects of disinfection on population recovery and mitigation of potential infection risk[J]. Am J Infect Control, 2012, 40(10):907-912.
|